ロード中...
Lenalidomide and Chronic Lymphocytic Leukemia
Lenalidomide is an oral immunomodulatory drug used in multiple myeloma and myelodysplastic syndrome and most recently it has shown to be effective in the treatment of various lymphoproliferative disorders such as chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma. The mechanism of action of...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi Publishing Corporation
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3791640/ https://ncbi.nlm.nih.gov/pubmed/24163824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/932010 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|